Written and maintained by CASRAI Editorial Board
Published
On this page
California Senate Bill 1120 (SB 1120)—formally titled the Physicians Make Decisions Act (Chapter 879, Statutes of 2024)—is a landmark California state statute authored by Senator Josh Becker, signed into law on September 28, 2024, and effective January 1, 2025. The law establishes enforceable statutory guardrails governing how health care service plans, disability insurers, and delegated utilization review (UR) organizations may deploy artificial intelligence (AI), machine learning algorithms, and automated decision-support software during prospective (prior authorization), concurrent, and retrospective utilization management reviews.
Enacted in response to federal investigations, class-action litigation, and empirical health services research examining high-volume algorithmic claim denials in commercial and managed care plans, California SB 1120 amends California Health and Safety Code Section 1367.01 (regulating health care service plans under the Knox-Keene Health Care Service Plan Act of 1975, overseen by the Department of Managed Health Care [DMHC]) and California Insurance Code Section 10123.135 (regulating disability health insurers overseen by the California Department of Insurance [CDI]). Together with federal Medicare Advantage prior authorization rules (42 CFR § 422.101) and comparable state AI utilization review laws, SB 1120 establishes the legal rule that an algorithm may approve a clinical service request, but only a licensed physician or qualified health care professional may deny, delay, or modify care based on medical necessity.
Ask CASRAI · free to tryQuestion about this guide? Ask CASRAI answers with linked sources. 2 free questions a day, no account.
What Is California SB 1120 and Which Entities Must Comply?
Under California’s dual health insurance regulatory structure, SB 1120 applies identically across both statutory codes to capture the full commercial and managed care market:
- Knox-Keene Health Care Service Plans (Health & Safety Code § 1367.01): Applies to all full-service and specialized health care service plans licensed by the DMHC (including HMOs, Medi-Cal managed care plans, and certain PPO products regulated under Knox-Keene).
- Disability Health Insurers (Insurance Code § 10123.135): Applies to all health and disability insurers issuing policies regulated by the CDI.
- Delegated Entities and Third-Party Utilization Review Vendors: Statutory compliance obligations extend explicitly to any medical group, independent practice association (IPA), management services organization (MSO), radiology benefit manager (RBM), pharmacy benefit manager (PBM), or third-party prior authorization software vendor that contracts with a plan or insurer to perform prospective, concurrent, or retrospective utilization review or utilization management functions.
Core Statutory Mandates of the Physicians Make Decisions Act
California SB 1120 does not prohibit payers from using artificial intelligence in health insurance claims and utilization management; instead, it regulates how algorithmic tools process clinical data and who holds legal authority to issue an adverse medical-necessity determination.
1. Prohibition on Autonomous Algorithmic Denials, Delays, or Modifications
The centerpiece of SB 1120 (Health & Safety Code § 1367.01(k)(2) and Insurance Code § 10123.135(j)(2)) mandates that any medical necessity determination must be made only by a licensed physician or a licensed health care professional who is competent to evaluate the specific clinical issues involved in the health care services requested by the provider. Specifically:
- An artificial intelligence, algorithm, or other software tool shall not deny, delay, or modify health care services based, in whole or in part, on medical necessity.
- Automated algorithms and rules engines may still be used to auto-approve prior authorization requests that meet clinical criteria, accelerating prior authorization reform turnaround targets.
- Whenever an algorithmic screening tool flags a prior authorization, concurrent stay review, or post-service medical necessity audit as not meeting automated approval criteria, the case must be routed to a qualified human clinician who independently reviews the requesting provider’s submitted clinical documentation before any denial, reduction in level of care, or modification is issued.
2. The 8 Statutory Requirements for AI and Algorithmic Utilization Review Tools
When a health care service plan, disability insurer, or delegated utilization review entity uses an AI, algorithm, or software tool as part of its utilization review or utilization management process, Health & Safety Code § 1367.01(k)(1) and Insurance Code § 10123.135(j)(1) mandate that the tool must comply with eight explicit statutory criteria:
| Statutory Criterion | Legal & Technical Requirement Under California SB 1120 | Operational Compliance Control for Payers & Vendors |
|---|---|---|
| 1. Individualized Clinical Data Basis | Must be based on the enrollee’s or insured’s medical or other clinical history and individual clinical circumstances as presented by the requesting provider, rather than solely on a group dataset | Ingests patient-specific EHR notes, lab panels, imaging reports, and prior therapy failures via HL7 FHIR Da Vinci DTR/PAS rather than relying on population-average length-of-stay cutoffs |
| 2. Publicly Accessible Clinical Criteria | Must be based on criteria and guidelines that are disclosed and publicly accessible to enrollees/insureds and contracted providers | Prohibits black-box proprietary denial thresholds that conceal the underlying clinical coverage criteria from the treating clinician |
| 3. Non-Supplanting of Provider Decision-Making | Must not directly or indirectly Causes or supplant health care provider decision-making | Requires human-in-the-loop (HITL) clinical review logs proving the reviewing physician exercised independent medical judgment rather than rubber-stamping bulk algorithmic queues |
| 4. Anti-Discrimination Compliance | Must not discriminate, directly or indirectly, against enrollees or insureds in violation of state or federal law (including Unruh Civil Rights Act and ACA Section 1557) | Mandates pre-deployment and ongoing subgroup fairness auditing across age, race, ethnicity, sex, and disability status |
| 5. Fair and Equitable Application | Must be fairly and equitably applied across covered populations | Standardizes model feature inputs and clinical guideline logic across plan tiers and geographic service areas |
| 6. Regulatory Inspection & Disclosure | Written policies and procedures governing how the AI/algorithm is used must be open to inspection and disclosed to the DMHC, CDI, enrollees, and providers | Maintains auditable model governance documentation, version histories, and utilization review policies for DMHC/CDI market conduct exams |
| 7. Periodic Performance & Accuracy Review | Performance, use, and outcomes of the tool must be periodically reviewed and revised to maximize accuracy and reliability | Tracks appeal overturn rates, clinician override rates, and calibration drift across clinical specialties |
| 8. Patient Data Privacy & Prohibited Training | Patient data must comply with the Confidentiality of Medical Information Act (CMIA, Civil Code § 56 et seq.) and HIPAA, and cannot be misused beyond lawful utilization review | Enforces strict data minimization, BAA/CMIA encryption, and zero unauthorized commercial monetization of enrollee clinical records |
How Is California SB 1120 Used in Clinical Research, Health Informatics, and Compliance Auditing?
For health informatics architects, revenue cycle compliance officers, and health policy researchers, California SB 1120 reshapes the technical design of automated utilization management pipelines:
- Bifurcated “Fast-Track Approval” vs. “Clinician Escalation” Architecture: In a compliant HL7 FHIR Da Vinci Prior Authorization Support (PAS) or ASC X12N 278 workflow, an NLP or rules engine may parse incoming clinical attachments (such as an HL7 FHIR
QuestionnaireResponseorDocumentReference) and immediately return an automated Certified in Total (A1) approval if all medical necessity criteria are met. However, if any criterion is missing or ambiguous, the software is blocked from issuing a Not Certified (A3) denial or Modified (A6) determination; it must route the complete clinical packet to a specialty-qualified human reviewer. - Audit Logging Against “Rubber-Stamp” Batch Denials: Before SB 1120, investigative reports documented payer workflows in which algorithms generated batch denial letters that medical directors signed in seconds without opening the underlying patient chart. Under SB 1120, DMHC and CDI regulators can audit EHR/UR workstation telemetry—including chart-open timestamps, specific clinical documents viewed, review duration, and the licensed reviewer’s specialty credentials—to verify that the human professional genuinely evaluated the enrollee’s individual clinical history.
- Alignment with Federal Medicare Advantage Rules (42 CFR § 422.101(c)): While Medicare Advantage plans are federally regulated by CMS rather than state insurance mandates, CMS codified parallel guardrails in the Contract Year 2024 Medicare Advantage Final Rule (CMS-4201-F) and 2024 FAQ guidance. Under 42 CFR § 422.101(c)(i), Medicare Advantage organizations may not rely on an algorithm or software that predicts length of stay based on large datasets without accounting for the individual patient’s medical history, physician recommendations, and published Medicare coverage criteria. SB 1120 extends and strengthens these individualized-review protections across California’s commercial and DMHC/CDI-regulated markets.
Frequently Asked Questions
What is California SB 1120?
California SB 1120, the Physicians Make Decisions Act (effective January 1, 2025), is a California law amending Health and Safety Code § 1367.01 and Insurance Code § 10123.135. It requires health plans, disability insurers, and delegated utilization review entities to ensure that any decision to deny, delay, or modify health care services based on medical necessity is made by a licensed physician or qualified health care professional—prohibiting artificial intelligence or algorithms from autonomously issuing medical necessity denials.
Does California SB 1120 ban AI in prior authorization completely?
No. SB 1120 permits health plans and insurers to use AI and automated algorithms for administrative routing, data extraction, and automated approval of prior authorization requests. The statute specifically prohibits AI from making the final adverse determination to deny, delay, or modify a requested medical service based on medical necessity, and requires any AI tool used in utilization review to evaluate the patient’s individualized clinical history rather than relying solely on group datasets.
What types of utilization review are covered by SB 1120?
California SB 1120 applies to all three temporal stages of utilization management: prospective review (pre-service prior authorization), concurrent review (ongoing inpatient length-of-stay or post-acute care extensions), and retrospective review (post-service medical necessity audits conducted before or after claim payment).







